ES2146555A1 - Utilization of formulations based on water-soluble fractions of phlebodium decumanum(exply-37) and polypodium leucotomos as nutritional supplement in the prevention and reversion of excessive physical effort syndrome - Google Patents

Utilization of formulations based on water-soluble fractions of phlebodium decumanum(exply-37) and polypodium leucotomos as nutritional supplement in the prevention and reversion of excessive physical effort syndrome

Info

Publication number
ES2146555A1
ES2146555A1 ES009900133A ES9900133A ES2146555A1 ES 2146555 A1 ES2146555 A1 ES 2146555A1 ES 009900133 A ES009900133 A ES 009900133A ES 9900133 A ES9900133 A ES 9900133A ES 2146555 A1 ES2146555 A1 ES 2146555A1
Authority
ES
Spain
Prior art keywords
exply
polypodium leucotomos
soluble fractions
reversion
utilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009900133A
Other languages
Spanish (es)
Other versions
ES2146555B1 (en
Inventor
Ferrer Miguel Yesares
Teresa Galvan Carlos De
Garcia Antonio Alcaide
Morillas Miguel Enriqu Yesares
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HELECHOS INTERNACIONAL HONDURA
Helsint SAL
Original Assignee
HELECHOS INTERNACIONAL HONDURA
Helsint SAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HELECHOS INTERNACIONAL HONDURA, Helsint SAL filed Critical HELECHOS INTERNACIONAL HONDURA
Priority to ES009900133A priority Critical patent/ES2146555B1/en
Priority to PCT/ES2000/000021 priority patent/WO2000043022A1/en
Publication of ES2146555A1 publication Critical patent/ES2146555A1/en
Application granted granted Critical
Publication of ES2146555B1 publication Critical patent/ES2146555B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Abstract

The formulations disclosed in the invention may contain water-soluble fractions of frond and rhizome of varieties of Phlebodium decumanum (EXPLY-37) and Polypodium leucotomos cultivated in the HE LSINT S.A.L. plantation near Yojoa lake (Honduras), and optionally rhizome of Phlebodium decumanum and Polypodium leucotomos and one or more amino acid components. Said formulations improve resistance and physical strength, restore and maintain immunologic balance by preventing the emergence of opportunistic infections, provide protection against exhaustion and tissue damage, especially bone, muscular and cartilaginous injuries under extreme effort conditions and reduce healing time once said injuries have occurred.
ES009900133A 1999-01-22 1999-01-22 USE OF FORMULATIONS BASED ON HYDRO-Soluble FRACTIONS OF PHLEBODIUM DECUMANUM (EXPLY-37) AND / OR POLYPODIUM LEUCOTOMOS AS A NUTRITIONAL COMPLEMENT IN THE PREVENTION AND REVERSION OF THE PHYSICAL ENVELOPE SYNDROME. Expired - Fee Related ES2146555B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES009900133A ES2146555B1 (en) 1999-01-22 1999-01-22 USE OF FORMULATIONS BASED ON HYDRO-Soluble FRACTIONS OF PHLEBODIUM DECUMANUM (EXPLY-37) AND / OR POLYPODIUM LEUCOTOMOS AS A NUTRITIONAL COMPLEMENT IN THE PREVENTION AND REVERSION OF THE PHYSICAL ENVELOPE SYNDROME.
PCT/ES2000/000021 WO2000043022A1 (en) 1999-01-22 2000-01-20 Utilization of formulations based on water-soluble fractions of phlebodium decumanum(exply-37) and polypodium leucotomos as nutritional supplement in the prevention and reversion of excessive physical effort syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009900133A ES2146555B1 (en) 1999-01-22 1999-01-22 USE OF FORMULATIONS BASED ON HYDRO-Soluble FRACTIONS OF PHLEBODIUM DECUMANUM (EXPLY-37) AND / OR POLYPODIUM LEUCOTOMOS AS A NUTRITIONAL COMPLEMENT IN THE PREVENTION AND REVERSION OF THE PHYSICAL ENVELOPE SYNDROME.

Publications (2)

Publication Number Publication Date
ES2146555A1 true ES2146555A1 (en) 2000-08-01
ES2146555B1 ES2146555B1 (en) 2001-03-01

Family

ID=8307037

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009900133A Expired - Fee Related ES2146555B1 (en) 1999-01-22 1999-01-22 USE OF FORMULATIONS BASED ON HYDRO-Soluble FRACTIONS OF PHLEBODIUM DECUMANUM (EXPLY-37) AND / OR POLYPODIUM LEUCOTOMOS AS A NUTRITIONAL COMPLEMENT IN THE PREVENTION AND REVERSION OF THE PHYSICAL ENVELOPE SYNDROME.

Country Status (2)

Country Link
ES (1) ES2146555B1 (en)
WO (1) WO2000043022A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306173B1 (en) * 1999-07-23 2001-05-30 Sigma Tau Healthscience Spa COMPOSITION FOR THE PREVENTION OF MUSCLE FATIGUE AND TO IMPROVE THE MUSCLE ENERGY PERFORMANCE.

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8104315A1 (en) * 1980-04-02 1981-04-16 Conrad Ltd Arthritis treatment with fern extracts
EP0503208A1 (en) * 1991-03-08 1992-09-16 Maracuyama International, S.A. Procedure for obtaining a natural water-soluble extract from the leaves and/or rhizomes of various immunologically active ferns
ES2068163B1 (en) * 1994-05-06 1995-09-01 Esp Farmaceuticas Centrum Sa PROCEDURE FOR OBTAINING A PLANT EXTRACT WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES.
ES2088770A1 (en) * 1995-02-23 1996-09-01 Esp Farmaceuticas Centrum Sa A pharmaceutical composition with activity in the treatment of cognitive and/or neuroimmune dysfunctions.
WO1998043499A2 (en) * 1997-04-01 1998-10-08 Sigma-Tau Healthscience S.P.A. Nutritional supplement

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8104315A1 (en) * 1980-04-02 1981-04-16 Conrad Ltd Arthritis treatment with fern extracts
EP0503208A1 (en) * 1991-03-08 1992-09-16 Maracuyama International, S.A. Procedure for obtaining a natural water-soluble extract from the leaves and/or rhizomes of various immunologically active ferns
ES2068163B1 (en) * 1994-05-06 1995-09-01 Esp Farmaceuticas Centrum Sa PROCEDURE FOR OBTAINING A PLANT EXTRACT WITH ACTIVITY IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AND / OR NEUROINMUNES.
ES2088770A1 (en) * 1995-02-23 1996-09-01 Esp Farmaceuticas Centrum Sa A pharmaceutical composition with activity in the treatment of cognitive and/or neuroimmune dysfunctions.
WO1998043499A2 (en) * 1997-04-01 1998-10-08 Sigma-Tau Healthscience S.P.A. Nutritional supplement

Also Published As

Publication number Publication date
ES2146555B1 (en) 2001-03-01
WO2000043022A1 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
WO2004043474A3 (en) Use of one or more elements from the group containing yttrium, neodymium and zirconium
AU1807295A (en) Shoe, in particular sport shoe or orthopaedic stocking with ankle stabilisation
WO2006069221A3 (en) Knee brace and method for securing the same
WO2003011239A3 (en) Sunscreen composition
CA2201310A1 (en) Antineoplastic cocoa extracts and methods for making and using the same
CA2178866A1 (en) Ankle brace with adjustable strap positioning fastener
WO2001080870A3 (en) Compositions derived from cranberry and grapefruit and therapeutic uses therefor
AU2525401A (en) Use of an extract of at least one vaccinium-type plant as an anti-glycation agent
EP1156770A4 (en) Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
WO2001045647A3 (en) Method for tabletting thickening systems
HRP20030046A2 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
WO2005034650A8 (en) Weight-loss supplement
HUP0302549A3 (en) Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
WO2008048821A3 (en) Mobile/fixed prosthetic knee systems
WO2008048820A3 (en) Mobile/fixed prosthetic knee systems
WO2008048819A3 (en) Mobile/fixed prosthetic knee systems
TW200637570A (en) Oral care compositions comprising a eucalyptus extract
CA2368574A1 (en) Compositions for preventing and treating type i allergy
MXPA05013667A (en) Dual component skin care compositions that comprise a self-tanning agent.
WO2004012655A3 (en) Anti-microbial compositions and methods of using same
AU4073901A (en) Novel pharmaceutical or dietetic mushroom-based compositions
EP1355654A4 (en) Lower alcohol-insoluble extract of hovenia dulcis var. koreana nakai, a polysaccharide isolated therefrom and an antihepatotoxic composition containing same
WO2005018560A3 (en) Methods of reducing risk of infection from pathogens
TW200731965A (en) Topical pain relief compositions of N,2,3-trimethyl-2-isopropylbutamide and methods for using the same
EP1602704A4 (en) Antioxidant, skin preparation for external use, cosmetic and food

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000801

Kind code of ref document: A1

Effective date: 20000801

FD2A Announcement of lapse in spain

Effective date: 20180807